Erin Michos to Adult
This is a "connection" page, showing publications Erin Michos has written about Adult.
Connection Strength
0.048
-
Psychological Factors and Their Association with Ideal Cardiovascular Health Among Women and Men. J Womens Health (Larchmt). 2018 05; 27(5):709-715.
Score: 0.012
-
Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020 12 18; 18(1):403.
Score: 0.004
-
Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease. J Gen Intern Med. 2019 11; 34(11):2427-2434.
Score: 0.003
-
Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials. Clin Nutr. 2020 06; 39(6):1742-1752.
Score: 0.003
-
Physical Activity, Fitness, and Cardiovascular Health: Insights From Publications in JAMA Network Open. JAMA Netw Open. 2019 08 02; 2(8):e198343.
Score: 0.003
-
Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults. JAMA Netw Open. 2019 07 03; 2(7):e197440.
Score: 0.003
-
Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial. Nutrients. 2018 Mar 17; 10(3).
Score: 0.003
-
Trends in calcium supplementation, National Health and Nutrition Examination Survey (NHANES) 1999-2014. Bone. 2018 06; 111:23-27.
Score: 0.003
-
Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines. Circulation. 2018 07 17; 138(3):244-254.
Score: 0.003
-
Does education modify the effect of ethnicity in the expression of ideal cardiovascular health? The Baptist Health South Florida Employee Study. Clin Cardiol. 2017 Nov; 40(11):1000-1007.
Score: 0.003
-
Trends in Use of High-Dose Vitamin D Supplements Exceeding 1000 or 4000 International Units Daily, 1999-2014. JAMA. 2017 06 20; 317(23):2448-2450.
Score: 0.003
-
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
Score: 0.003